Products

Norvayo

Find your way forward, one pouch at a time.

norvayo.com Google PlayHealth & Wellness / Addiction & Quitting

AI Benchmark
Desktop
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
Joshua Jorgenson
No social account linked
Launched
3mo ago
2026-09-03 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Quit nicotine on your terms.

    Sep 3 · 3mo agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-07-24

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
$0
One accountability partner · 7-day trend charts
Premium
Unknown
14, 30, and 90-day trend charts

Trial: Every new account gets 14 days of Premium, no card required. · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-09-03

Key pages

Weekly snapshots
Home
norvayo.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Norvayo cost?
Free: $0; Premium: Unknown. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Norvayo get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Norvayo and what platforms does it support?
Norvayo is catalogued under Addiction & Quitting: Find your way forward, one pouch at a time. Supported platforms: Mobile App.

Related products in this category

Health & Wellness / Addiction & Quitting

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.